<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04244487</url>
  </required_header>
  <id_info>
    <org_study_id>YZUC-004</org_study_id>
    <nct_id>NCT04244487</nct_id>
  </id_info>
  <brief_title>Laparoscopic Splenectomy and Azygoportal Disconnection With Intraoperative Endoscopic Variceal Ligation</brief_title>
  <acronym>SVEL</acronym>
  <official_title>Vagus Nerve-preserving Laparoscopic Splenectomy and Azygoportal Disconnection With Versus Without Intraoperative Endoscopic Variceal Ligation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yangzhou University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yangzhou University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to evaluate whether synchronous vagus nerve-preserving laparoscopic
      splenectomy and azygoportal disconnection with intraoperative endoscopic variceal ligation
      (SVEL) is effective and safe, and to determine whether SVEL can effectively decrease the
      incidence of postoperative esophageal variceal re-bleeding.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After successful screening the cases of cirrhosis of liver irrespective of the etiology who
      have prior esophageal/gastroesophageal variceal bleeding will be enrolled. The baseline
      parameter will be recorded and the patient will be randomized into either interventional
      (synchronous vagus nerve-preserving laparoscopic splenectomy and azygoportal disconnection
      with intraoperative endoscopic variceal ligation (SVEL)) or control (single vagus
      nerve-preserving laparoscopic splenectomy and azygoportal disconnection without
      intraoperative endoscopic variceal ligation (SVEL)) group. From postoperative day 3, all
      patients will receive 100 mg oral aspirin enteric-coated tablets (Bayer, Leverkusen, Germany)
      once daily for 1 year, low-molecular-weight heparin (CS Bio, Hebei, China) subcutaneously
      (4.100 IU/day) for 5 days, and 25 mg of oral dipyridamole (Henan Furen, Henan, China) thrice
      daily for 3 months. At months 3, 6, and 12 after operation, endoscopic intervention will be
      done for all patients. Endoscopic variceal ligation was made if the diameter of the
      esophageal varices was &gt;5 mm. Postoperative complications of esophageal variceal re-bleeding
      and death due to re-bleeding will be recorded during the postoperative first year monitoring
      in the both groups as per the primary or secondary outcome.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 3, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Esophageal variceal re-bleeding</measure>
    <time_frame>1 year</time_frame>
    <description>Proportions of patients who will suffer from esophageal variceal re-bleeding</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Death due to re-bleeding</measure>
    <time_frame>1 year</time_frame>
    <description>Proportions of patients who will suffer from death due to re-bleeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival</measure>
    <time_frame>1 year</time_frame>
    <description>Overall survival in both groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cirrhosis</condition>
  <condition>Hypertension</condition>
  <condition>Splenectomy</condition>
  <condition>Laparoscopy</condition>
  <arm_group>
    <arm_group_label>intraoperative endoscopic variceal ligation group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intraoperative endoscopic variceal ligation group Every patient of vagus nerve-preserving group will receive the synchronous vagus nerve-preserving laparoscopic splenectomy and azygoportal disconnection with intraoperative endoscopic variceal ligation procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-intraoperative endoscopic variceal ligation group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Every patient of conventional group will receive single vagus nerve-preserving laparoscopic splenectomy and azygoportal disconnection without intraoperative endoscopic variceal ligation procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic splenectomy and azygoportal disconnection with intraoperative endoscopic variceal ligation</intervention_name>
    <description>The modified procedure was implemented in the following order: (1) find the left crural diaphragm; (2) via the surface of the left crural diaphragm, divide the left lateral surface of the distal esophagus; (3) divide the posterior surface of the distal esophagus; (4) divide the anterior surface of the distal esophagus; (5) divide the lesser omental sac via the bottom right crural diaphragm; (6) transect en bloc the left gastric artery and vein and posterior gastric veins using a linear laparoscopic vascular stapler; (7) find the right crural diaphragm by dividing a small portion of the hepatogastric ligament at the left lateral esophagogastric junction; and (8) via the surface of the right crural diaphragm, divide the right lateral surface of the distal esophagus.
After the procedure of laparoscopic azygoportal disconnection, intraoperative endoscopic variceal ligation was made if the diameter of the esophageal varices was &gt;5 mm.</description>
    <arm_group_label>intraoperative endoscopic variceal ligation group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A clinical, radiological or histologic diagnosis of cirrhosis of any etiology

          -  Splenomegaly with secondary hypersplenism

          -  esophageal/gastroesophageal variceal bleeding

          -  No evidence of portal vein system thrombosis by ultrasound evaluation and angio-CT

          -  Informed consent to participate in the study

        Exclusion Criteria:

          -  Hepatocellular carcinoma or any other malignancy,

          -  Hypercoagulable state other than the liver disease related

          -  DRUGS- oral contraceptives, anticoagulation or anti-platelet drugs.

          -  Child - Pugh C

          -  Recent peptic ulcer disease

          -  History of Hemorrhagic stroke

          -  Pregnancy

          -  Uncontrolled Hypertension

          -  Age&gt;75 yrs

          -  Human immunodeficiency virus (HIV) infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luo-Jing Zhou, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Clinical Medical College, Yangzhou University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Guo-Qing Jiang, MD</last_name>
    <phone>+8651487373382</phone>
    <email>jgqing2003@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dou-sheng Bai, MD</last_name>
    <phone>86-514-87373275</phone>
    <email>bdsno1@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinical Medical College, Yangzhou University</name>
      <address>
        <city>Yangzhou</city>
        <state>Jiangsu</state>
        <zip>225001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luo-Jing Zhou, MD</last_name>
      <phone>86-514-87373037</phone>
      <email>luojing76@163.com</email>
    </contact>
    <investigator>
      <last_name>Dou-Sheng Bai, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 18, 2020</study_first_submitted>
  <study_first_submitted_qc>January 26, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 28, 2020</study_first_posted>
  <last_update_submitted>January 26, 2020</last_update_submitted>
  <last_update_submitted_qc>January 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yangzhou University</investigator_affiliation>
    <investigator_full_name>Guo-Qing Jiang</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <keyword>Vagus nerve</keyword>
  <keyword>Esophageal variceal re-bleeding</keyword>
  <keyword>Cirrhosis</keyword>
  <keyword>Hypertension</keyword>
  <keyword>laparoscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

